Inhibitor of DNA-dependent protein kinase
(DNA-PK) (IC50 = 15 μM), an enzyme
involved in the non-homologous end-joining (NHEJ) pathway of double-stranded
DNA break (DSB) repair in human cells. Displays 100-fold higher potency than
its analogue vanillin and does not affect PKC activity. Produces lethal effects
on cisplatin-treated D5037 cells upon continuous exposure.